DLB profile · all as-reported value updates
Dolby Laboratories, Inc. (DLB) as-reported value updates
Descriptive filing record — not investment advice. This page compares two SEC XBRL-filed values for the same fiscal period. It does not state why the values differ and is not a rating, score, or recommendation. See Disclaimer.
Reported values for the same fiscal period can differ between filings for many routine reasons: re-presentation for discontinued operations, adoption of new accounting standards, reclassifications, changes in rounding precision, and amendments. This ledger records that the filed values differ; it does not and cannot determine why. Both filings are linked below so the reader can consult the source.
Ledger table figure
| Metric | FY | Earliest XBRL-filed value | Currently on file | Difference | Difference % | Label | Filing links | Notes |
|---|---|---|---|---|---|---|---|---|
| Net income | 2018 | 122,246,000 | 41,746,000 | -80,500,000 | -65.85% | revised comparative figure | 0001628280-18-014390 0001628280-20-016459 | 3 filed observations examined for this concept and period. |
| Operating income | 2018 | 299,998,000 | 183,505,000 | -116,493,000 | -38.83% | revised comparative figure | 0001628280-18-014390 0001628280-20-016459 | 3 filed observations examined for this concept and period. |
| Gross profit | 2018 | 1,043,664,000 | 927,038,000 | -116,626,000 | -11.17% | revised comparative figure | 0001628280-18-014390 0001628280-20-016459 | 3 filed observations examined for this concept and period. |
| Stockholders' equity | 2018 | 2,189,551,000 | 2,363,936,000 | 174,385,000 | +7.38% | revised comparative figure | 0001628280-18-014390 0001628280-19-014472 | 2 filed observations examined for this concept and period. |
| Assets | 2018 | 2,659,269,000 | 2,865,387,000 | 206,118,000 | +7.19% | revised comparative figure | 0001628280-18-014390 0001628280-19-014472 | 2 filed observations examined for this concept and period. |
| Liabilities | 2018 | 463,151,000 | 494,884,000 | 31,733,000 | +6.41% | revised comparative figure | 0001628280-18-014390 0001628280-19-014472 | 2 filed observations examined for this concept and period. |
| Net income | 2017 | 201,802,000 | 206,481,000 | 4,679,000 | +2.27% | revised comparative figure | 0001628280-17-011633 0001628280-19-014472 | 3 filed observations examined for this concept and period. |
| Operating cash flow | 2017 | 371,051,000 | 377,793,000 | 6,742,000 | +1.78% | revised comparative figure | 0001628280-17-011633 0001628280-19-014472 | 3 filed observations examined for this concept and period. |
| Cash and cash equivalents | 2017 | 627,017,000 | 634,368,000 | 7,351,000 | +1.16% | revised comparative figure | 0001628280-17-011633 0001628280-19-014472 | 3 filed observations examined for this concept and period. |